146 related articles for article (PubMed ID: 2030600)
41. Specific binding of anti-N-acetyllactosamine monoclonal antibody 1B2 to acute myeloid leukaemia cells.
Campos L; Portoukalian J; Bonnier S; Shi ZH; Calmard-Oriol P; Treille D; Guyotat D
Eur J Cancer; 1992; 28(1):37-41. PubMed ID: 1567687
[TBL] [Abstract][Full Text] [Related]
42. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
[TBL] [Abstract][Full Text] [Related]
43. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
Roodman GD; Bird A; Hutzler D; Montgomery W
Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of "discordant maturation' in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM).
Marley SB; Lewis JL; Scott MA; Goldman JM; Gordon MY
Br J Haematol; 1996 Nov; 95(2):299-305. PubMed ID: 8904885
[TBL] [Abstract][Full Text] [Related]
45. Expression of tumor-associated surface membrane antigens on marrow CFU-s, CFC-gm, BFU-e, and brain CFU-s.
Hasthorpe S; Bartlett PF; Rogerson J
Int J Cell Cloning; 1985 Jan; 3(1):10-21. PubMed ID: 3973426
[TBL] [Abstract][Full Text] [Related]
46. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
[TBL] [Abstract][Full Text] [Related]
47. A fractionation procedure of mouse bone marrow cells yielding exclusively pluripotent stem cells and committed progenitors.
Bauman JG; Wagemaker G; Visser JW
J Cell Physiol; 1986 Jul; 128(1):133-42. PubMed ID: 2424920
[TBL] [Abstract][Full Text] [Related]
48. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
[TBL] [Abstract][Full Text] [Related]
49. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
50. Restricted expression of a new acute myelogenous leukemia-associated antigen (NHL-30.5) on normal hemopoietic progenitor cells.
Askew DS; Eaves AC; Eaves CJ; Takei F
Blood; 1986 Apr; 67(4):1098-102. PubMed ID: 3456804
[TBL] [Abstract][Full Text] [Related]
51. Cellular and cytokine-mediated effects of CD4-positive lymphocyte lines generated in vitro against chronic myelogenous leukemia.
Jiang YZ; Barrett AJ
Exp Hematol; 1995 Oct; 23(11):1167-72. PubMed ID: 7556526
[TBL] [Abstract][Full Text] [Related]
52. Antigenic analysis of hematopoiesis: II. Expression of human neutrophil antigens on normal and leukemic marrow cells.
Strauss LC; Skubitz KM; August JT; Civin CI
Blood; 1984 Mar; 63(3):574-8. PubMed ID: 6696993
[TBL] [Abstract][Full Text] [Related]
53. Isolation of hemopoietic progenitor cells from human umbilical cord blood.
Bodger MP
Exp Hematol; 1987 Sep; 15(8):869-76. PubMed ID: 3622658
[TBL] [Abstract][Full Text] [Related]
54. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
[TBL] [Abstract][Full Text] [Related]
55. CD34+ leukemic cells assessed by different CD34 monoclonal antibodies.
Lanza F; Moretti S; Castagnari B; Latorraca A; Rigolin GM; Bardi A; Castoldi G
Leuk Lymphoma; 1995; 18 Suppl 1():25-30. PubMed ID: 7496351
[TBL] [Abstract][Full Text] [Related]
56. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens:absence of reactivity with normal hematopoietic progenitor cells.
Muroi K; Suda T; Nojiri H; Ema H; Amemiya Y; Miura Y; Nakauchi H; Singhal A; Hakomori S
Blood; 1992 Feb; 79(3):713-9. PubMed ID: 1370643
[TBL] [Abstract][Full Text] [Related]
57. 12-O-tetradecanoylphorbol-13-acetate (TPA) downregulates expression of CD30 in erythroleukemia cell line K562.
Ezawa H; Harigaya K; Ishii G; Nakajima N; Mikata A
Hematol Oncol; 1997 Aug; 15(3):151-61. PubMed ID: 9600114
[TBL] [Abstract][Full Text] [Related]
58. Purification of haemopoietic progenitor cells from patients with chronic granulocytic leukaemia using percoll density gradients and elutriation.
Martin H; Hibbin JA; Dowding C; Matutes E; Tindle R; Goldman JM
Br J Haematol; 1986 May; 63(1):187-98. PubMed ID: 3011059
[TBL] [Abstract][Full Text] [Related]
59. HLA-DR monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cells.
Goldman JM; Hibbin J; Kearney L; Orchard K; Th'ng KH
Br J Haematol; 1982 Nov; 52(3):411-20. PubMed ID: 6957244
[TBL] [Abstract][Full Text] [Related]
60. Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.
Scheinberg DA; Tanimoto M; McKenzie S; Strife A; Old LJ; Clarkson BD
Leukemia; 1989 Jun; 3(6):440-5. PubMed ID: 2725060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
